NCT00038428View on ClinicalTrials.gov

Phase 2 Study of TLK286 in Platinum Resistant Advanced Epithelial Ovarian Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

June 30, 2001

Primary Completion Date

July 31, 2005

Study Completion Date

July 31, 2005

Conditions
Ovarian Neoplasms
Interventions
DRUG

TLK286

Trial Locations (3)

10021

Memorial Sloan-Kettering Cancer Center, New York

77030

M.D. Anderson Cancer Center, Houston

90033

USC/Norris Comprehensive Cancer Center, Los Angeles

Sponsors

Lead Sponsor

Telik
All Listed Sponsors
lead

Telik

INDUSTRY